Data is not available at this time.
Mettler-Toledo International Inc. operates as a global leader in precision instruments and services, primarily serving laboratory, industrial, and food retail sectors. The company generates revenue through the sale of high-precision weighing instruments, analytical tools, and automated laboratory solutions, complemented by recurring income from service contracts and software subscriptions. Its diversified product portfolio includes balances, pipettes, titrators, and process analytics systems, catering to stringent quality control and regulatory requirements across pharmaceuticals, chemicals, and food production. Mettler-Toledo holds a dominant position in laboratory weighing and process analytics, supported by its strong R&D focus and global distribution network. The company differentiates itself through technological innovation, reliability, and deep industry expertise, enabling premium pricing and long-term customer relationships. Its market leadership is reinforced by a reputation for accuracy, compliance with international standards, and integration of IoT-enabled solutions for data-driven decision-making in industrial and scientific applications.
Mettler-Toledo reported revenue of $3.87 billion for FY 2024, with net income of $863.1 million, reflecting a robust net margin of approximately 22.3%. Diluted EPS stood at $40.67, underscoring efficient earnings conversion. Operating cash flow reached $968.3 million, while capital expenditures of $103.9 million indicate disciplined reinvestment, yielding strong free cash flow generation.
The company demonstrates high earnings power, with operating cash flow covering capital expenditures by a factor of 9.3x. Its capital-light model and focus on high-margin recurring services contribute to superior returns on invested capital. The absence of dividends suggests reinvestment in growth initiatives, further enhancing long-term capital efficiency.
Mettler-Toledo maintains $59.4 million in cash against total debt of $2.01 billion, reflecting a leveraged but manageable position. The debt load is offset by strong cash flow generation, with operating cash flow covering 48% of total debt. The balance sheet supports ongoing innovation and market expansion without immediate liquidity concerns.
Revenue growth is driven by demand for precision instruments in life sciences and industrial automation, with recurring services providing stability. The company does not pay dividends, prioritizing organic growth and strategic acquisitions. Share count remains stable at 21.2 million, indicating minimal dilution and disciplined capital allocation.
The market values Mettler-Toledo at a premium, reflecting its leadership in niche precision markets and consistent profitability. High EPS and cash flow multiples suggest expectations of sustained growth, particularly in automated lab solutions and emerging markets. Investor confidence is bolstered by its innovation pipeline and resilient end-market demand.
Mettler-Toledo’s competitive edge lies in its technological expertise, global service network, and regulatory compliance capabilities. Near-term growth will likely stem from lab automation and Industry 4.0 adoption, though macroeconomic pressures on industrial spending pose risks. The outlook remains positive, supported by secular trends in biopharma and food safety investments.
Company filings (10-K), Bloomberg
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |